EZR and esophageal squamous cell carcinoma: In addition, the phosphorylation of ERK was reduced in ezrin‐KD cells, and activation of the ERK/MAPK pathway may partially attenuate the Ezrin‐mediated suppression of cell invasiveness in esophageal SCC (Xie et al., 2009).